Skip to content


The chemotherapy drugs Doxorubicin and Dacarbazine, when used in combination, constitute a chemotherapy regimen for treating soft tissue sarcomas, especially Leiomyosarcoma, which grows in the smooth muscles. Understanding the intricacies of this treatment, including its administration, potential side effects, and precautionary measures, is essential for patients to actively engage in their care and enhance treatment outcomes.